Table 3. Correlation of promoter methylation of MGMT, CDH1, RARb and SYK in ovarian carcinomas.
| Methylated | Unmethylated | P-value | |
|---|---|---|---|
| MGMT methylation status | |||
| CDH1 methylation status | |||
| Methylated | 9 | 0 | 0.001* |
| Unmethylated | 5 | 11 | |
| RAR-β methylation status | |||
| Methylated | 7 | 1 | 0.0421* |
| Unmethylated | 7 | 10 | |
| SYK methylation status | |||
| Methylated | 4 | 2 | 0.6609 |
| Unmethylated | 10 | 9 | |
| CDH1 methylation status | |||
| RAR-β methylation status | |||
| Methylated | 7 | 1 | 0.0005* |
| Unmethylated | 2 | 15 | |
| SYK methylation status | |||
| Methylated | 3 | 4 | 1 |
| Unmethylated | 6 | 11 | |
| RAR-β methylation status | |||
| SYK methylation status | |||
| Methylated | 2 | 5 | 1 |
| Unmethylated | 6 | 12 | |
*
Significant at P< 0.05.